Panion & Bf Biotech Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 454.57 million compared to TWD 374.05 million a year ago. Net income was TWD 39.55 million compared to net loss of TWD 24.79 million a year ago. Basic earnings per share from continuing operations was TWD 0.46 compared to basic loss per share from continuing operations of TWD 0.32 a year ago. Diluted earnings per share from continuing operations was TWD 0.46 compared to diluted loss per share from continuing operations of TWD 0.32 a year ago.